News

The first new Phase IIb clinical trial (Taski 2) will evaluate RA patients receiving 100mg of R788 PO bid (orally, twice daily) or 150mg PO qd (orally, once

Under the terms of the agreement, Lilly will obtain exclusive worldwide rights to TransPharma’s ViaDerm-hPTH (1-34) product and will also gain non-exclusive access to TransPharma’s ViaDerm drug delivery

GlaxoSmithKline’s Tyverb (lapatinib), in combination with capecitabine, is indicated for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress ErbB2. The authorization was based

The primary objective of this Phase I/II clinical trial was to determine the tolerability and safety profile of repeated administration of CTCE-9908. The secondary objective was to evaluate

The trial is designed to investigate two small molecule radiopharmaceutical candidates that target prostate-specific membrane antigen, MIP-1072 and MIP-1095, in order to select a lead candidate for further

This clinical trial comprises three discrete phases which allows for evaluation of efficacy and safety of Traficet-EN in inducing a clinical response or remission, as well as maintaining

Braemar’s ER920W is a digital loop recorder with on-board arrhythmia detection algorithms for automatic detection, recording and immediate transmission of patient data files to a service center for

The agreement will enable health care providers to inject Fluorodeoxyglucose (FDG) for positron emission tomography/computed tomography (PET/CT) imaging procedures in a new way. The partnership will leverage Medrad’s

The Comet trial also showed that 50% of patients taking this Enbrel combination achieved clinical remission and nearly 55% achieved functional remission compared to 28% and 39%, respectively,